Rare Presentation Of Sarcoidosis-Sarcoidal Reaction In A Tattoo
- byDoctor News Daily Team
- 13 July, 2025
- 0 Comments
- 0 Mins
Dr Darosa Lim and colleagues, at Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada have reported a rare case of Sarcoidal Reaction in a Tattoo.The case has appeared in the New England Journal of Medicine.
Sarcoidosis is a granulomatous disease of unknown etiology. It may affect any organ in the body although the lungs are most commonly involved.A sarcoidal reaction in a tattoo may be an isolated finding or it may represent a cutaneous sign of systemic disease. Reactions in cosmetic tattoos relating to sarcoidosis have been reported as early as 1952.1,2 The cause of sarcoidal reactions in tattoos remains unknown. This finding may be a specific cutaneous manifestation of sarcoidosis in which the pigment in tattoos acts as a nidus for granuloma formation; such reactions may be the only manifestation of cutaneous sarcoidosis.
A 42-year-old man presented to the dermatology clinic with a 5-month history of numerous papules along with the pattern of his tattoos, which he had received 10 years earlier (Panel A). There was no associated pain or pruritus. He reported that he had not had any dyspnea, fever, arthralgias, visual symptoms, or other systemic symptoms, and the remainder of his physical examination was normal.
A biopsy of the papules showed noncaseating granulomas with black and brown pigment within the superficial and deep dermis (Panel B, arrow), which supported the diagnosis of a cutaneous sarcoidal reaction. Tissue cultures for bacteria, mycobacteria, and fungi were negative. Thoracic computed tomography revealed bilateral hilar and mediastinal lymphadenopathy with no parenchymal abnormalities. Further investigation for systemic sarcoidosis, including ophthalmic, pulmonary function, and cardiac testing, was negative.
Granulomatous reactions to tattoo ink or scars may occur years after the provoking event. The patient's skin lesions resolved after several months of treatment with a potent topical glucocorticoid.
For further reference log on to :
DOI: 10.1056/NEJMicm1909931
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Tags:
Recent News
Eli Lilly plans to build new USD 3 billion facilit...
- 04 November, 2025
Rajkot Maternity Hospital CCTV Leak: How a simple...
- 04 November, 2025
Gland Pharma profit rises 12 percent to Rs 184 cro...
- 04 November, 2025
AIIMS Delhi doctors told to use Hindi in prescript...
- 04 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!